APPLICATIONS PUBLISHED 19 JUNE 2002
Published: 1-Dec-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Adjuvant comprising a polyethoxyethylene alkyl ether or ester and at least one nonionic surfactant
SmithKline Beecham Biologicals 1214053*
Intranasal influenze virus vaccine
SmithKline Beecham Biologicals 1214054*
Pharmaceutical gel containing active substances
Hexal 1214055*
Topical suspension formulations containing ciprofloxacin and dexamethasone
Alcon Universal 1214056*
Vascular coating compsn
Cryolife 1214057*
Method to obtain microparticles
AstraZeneca 1214058*
Surface modulated particulate compsns of biologically active substances
RTP Pharma 1214059*
Method of inhibiting protein tyrosine phosphatase 18B and/or T-cell protein tyrosine phosphatases and/or other PTPases with an ASP residue at position 48
Novo Nordisk; Ontogen 1214060*
Use of docetaxel for treating hepatocellular carcinoma
Aventis Pharma 1214061*
Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
Inspire Pharmaceuticals 1214062*
Method of treating cancer using tetraethyl thiuram disulphide
Charlotte-Mecklenburg Hospital Authority 1214063*
Systems for agitated delivery of anti-infective compsns to treat disordered tissue such as cold sores
Johnson, B Ron 1214064*
A method for optimising pupil size using alpha antagonist
Horn, Gerald 1214065*
Formations of nanometer-scale structures
Atwood, Jerry 1214066*
Method of treating cell proliferative disorders including cancer
EFA Sciences 1214067*
Ophthalmic fluid
Planned Products 1214068*
High affinity DNA binding compounds as adjuvants in antisense technology
Virginia Commonwealth University 1214069*
Polyhydroxylated benzene-containing compounds
Arch Development Corp 1214070*
Treating allergic and inflammatory conditions using desloratadine
Schering 1214071*
Use of deloratadine for treating allergic and inflammatory conditions
Schering 1214072*
Use of dexrazoxane for treating psoriasis
Cyanthus Exquiere Pharmaforschungs 1214073*
Dioxolane nucleoside analogues for the treatment or prevention of viral infection
Shire Biochem 1214074*
Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
Schering 1214075*
Pharmaceutical combinations of ethinylestradiol and drospirenone for use as a contraceptive
Schering 1214076*
Local delivery of 17-beta estradiol for preventing vascular intima hyperplasia and for improving vascular endothelium function after vascular injury
Institut de Cardiologie de Montreal 1214077*
Formulations for parenteral use of estramustine phosphate and amino acids
Pharmacia Italia 1214078*
Drug for treating fractures
The Royal Alexandra Hospital for Children 1214079*
Glucosamine and egg for reducing inflammation
DCV 1214080*
Superoxidised water based on hypochlorous acid for the treatment of wounds
Sterilox Europe 1214081*
Methods and compsns for reducing immune response
Canji 1214082*
Solid phase assay
The Liposome Corp 1214083*
An antioxidant preparation based on plant extracts for the treatment of circulation and adiposity problems
Ceteris Holding 1214084*
A antioxidant formulation based on plant extracts for the treatment of circulation and chronic degenerative problems and of hypertension
Ceteris Holding 1214085*
Method for the therapeutic management of endometriosis and fallopian tube obstruction
Zentaris 1214086*
Combination treatments with IL-1RA and compounds that inhibit IL-1 processing and release
Pfizer Products 1214087*
Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
The Public Health Research Institute of the City of New York 1214088*
